Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2003
03/11/2003US6531315 Stimulating or expanding T cells (which are specific for cells expressing tumor proteins) by contacting them with given amino acid sequence
03/11/2003US6531312 Isolated nucleic acid of given sequence
03/11/2003US6531306 Polynucleotides encoding mammalian DNA-dependent ATPase A polypeptides
03/11/2003US6531302 Using primer pair sets anchored to a microarray through capture sites or through a branched primer pair moiety; allows for simultaneous multiplex capture, amplification, and detection of a target nucleic acid
03/11/2003US6531301 Nucleic acid-free thermostable enzymes and methods of production thereof
03/11/2003US6531300 To transcribe deoxynucleotides using primers; advantage of forming multiple single stranded copies
03/11/2003US6531297 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
03/11/2003US6531292 Genes and proteins controlling cholesterol synthesis
03/11/2003US6531291 Antimicrobial activity of gemfibrozil and related compounds and derivatives and metabolites thereof
03/11/2003US6531290 Mammalian TNF- α convertase
03/11/2003US6531289 Modulation of proteins using metal ion-responsive element; use in isolation, screening and analysis of antifungal compounds
03/11/2003US6531286 Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
03/11/2003US6531285 Automated detection apparatus with a conveying means for test columns
03/11/2003US6531284 Subjecting polynucleotide to a two-hybrid screening method (mating); selecting the recombinant diploid yeast cell for which the detectable gene has been expressed
03/11/2003US6531283 Protein expression profiling
03/11/2003US6531282 Short tandem repeat (STR); determining fragment lengths of alleles in DNA by polymerase chain reaction which produces mixture of labeled amplicons
03/11/2003US6531281 Method of detecting sulphate-reducing bacteria
03/11/2003US6531280 Method for identifying or isolating a molecule and molecules identified thereby
03/11/2003US6531279 Genomic sequence of the 5-lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma
03/11/2003US6531276 Using probes to determine duplex formation; use in diagnostic, prophylactic, and therapeutic applications
03/11/2003US6531138 Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypetides and peptides in the diagnostic of tuberculosis
03/11/2003US6531137 Retrovirus from the HIV group and its use
03/11/2003US6531129 Heparanase specific molecular probes and their use in research and medical applications
03/11/2003US6531040 Electrochemical-sensor design
03/11/2003CA2099543C Photochemical labelling of nucleic acids with digoxigenin reagents and their use in gene probe test systems
03/11/2003CA2050276C Improved primer extension reactions
03/07/2003CA2402048A1 Method and system for faster and more sensitive homology searching
03/06/2003WO2003019451A1 A method and system for defining gene hunting studies
03/06/2003WO2003019198A2 Methods relating to treatment of atherosclerosis
03/06/2003WO2003019196A2 Diagnosis and treatment of atherosclerosis
03/06/2003WO2003019195A2 Cellular immunity test with peptides fixed on a solid support
03/06/2003WO2003019194A2 Displacement assay for detecting ligate-ligand association events
03/06/2003WO2003019189A1 Homogeneous phase gene microarray
03/06/2003WO2003019171A1 Methods for producing highly sensitive potentiometric sensors
03/06/2003WO2003019170A1 Self-powered biosensor
03/06/2003WO2003019147A2 Enzyme-amplified redox microarray detection process
03/06/2003WO2003019146A2 High throughput screening assays using fatty acid synthetic enzymes
03/06/2003WO2003019145A2 Non-fluorescent quencher compounds and biomolecular assays
03/06/2003WO2003019143A2 Fluorescent multiplex hpv pcr assays using multiple fluorophores
03/06/2003WO2003019141A2 Analysis of circulating tumor cells, fragments, and debris
03/06/2003WO2003019138A2 Bio-sensing platforms for detection and quantitation of biological molecules
03/06/2003WO2003018847A1 Effect of bdnf genotype on hippocampal function and verbal memory and risk for schizophrenia
03/06/2003WO2003018846A1 Affinity tag modified particles
03/06/2003WO2003018845A1 Method for identifying fast-growing fish in different salinity
03/06/2003WO2003018844A1 Method and apparatus for three label microarrays
03/06/2003WO2003018843A1 Gene polymorphisms and response to treatment
03/06/2003WO2003018842A1 Novel gene nedl-1
03/06/2003WO2003018841A1 Method of judging mismatch between single-stranded nucleic acid molecules
03/06/2003WO2003018840A1 Method of evaluating degree of canceration of mammal-origin specimen
03/06/2003WO2003018839A1 Identification of a common promoter module in disease associated genes
03/06/2003WO2003018838A2 Interaction detection on several probe arrays
03/06/2003WO2003018837A2 Method and diagnostic kit for the molecular diagnosis of pharmacologically relevant genes
03/06/2003WO2003018836A2 Model of autoimmune disease and methods for identifying agents against autoimmune disease
03/06/2003WO2003018835A2 Method for rapid detection of haplotypes
03/06/2003WO2003018834A2 Displacement assay for the detection of nucleic acid oligomer hybridization events
03/06/2003WO2003018833A2 3-hydroxymethylglutaryl coenzyme a reductase and diagnosis and prognostication of dementia
03/06/2003WO2003018832A1 Methods for quantifying nuclear run-on transcriptional assays
03/06/2003WO2003018831A2 Primers and method for the genotyping of snps by multiplex pcr
03/06/2003WO2003018830A2 METHOD TO IDENTIFY MODULATORS FOR HUMAN 3α-HYDROXYSTEROID DEHYDROGENASE
03/06/2003WO2003018817A1 Yeast membrane protein expression system and its application in drug screening
03/06/2003WO2003018813A2 Ashbya gossypii enzymes
03/06/2003WO2003018807A1 Nucleic acids showing difference in expression between hepatoblastoma anc normal liver
03/06/2003WO2003018803A1 Established fat cell precursors, method of preparing the same and method of using the same
03/06/2003WO2003018801A1 Cd36/fat gene promoter and diagnosis of disease associated with cd36/fat gene
03/06/2003WO2003018799A2 Modulators of bone homeostasis identified in a high-throughput screen
03/06/2003WO2003018798A2 G-protein coupled receptor and dna sequences thereof
03/06/2003WO2003018792A1 Method of detecting toxic substance
03/06/2003WO2003018791A1 Method of detecting toxic substance
03/06/2003WO2003018775A2 Human mitochondrial dna polymorphisms, haplogroups, associations with physiological conditions, and genotyping arrays
03/06/2003WO2003018770A2 Amplified oncogenes and their involvement in cancer
03/06/2003WO2003018769A2 Amplified gene involved in cancer
03/06/2003WO2003018768A2 Transmembrane protein differentially expressed in cancer
03/06/2003WO2003018765A2 A high throughput method for identification of sequence tags
03/06/2003WO2003018761A2 Compositions and methods for generating antigen-binding units
03/06/2003WO2003018760A2 Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy
03/06/2003WO2003018757A2 Stabilization of cells and biological specimens for analysis
03/06/2003WO2003018756A2 Methods for preparing purified prostaglandin e synthase
03/06/2003WO2003018755A2 Wild-type ras as a cancer therapeutic agent
03/06/2003WO2003018754A2 Neural regeneration peptide and methods for their use in treatment of brain damage
03/06/2003WO2003018749A2 Compositions and methods for generating antigen-binding units
03/06/2003WO2003018747A2 Molecular interaction sites of hepatitis c virus rna and methods of modulating the same
03/06/2003WO2003018746A2 Estrogen receptor alpha variants and methods of detection thereof
03/06/2003WO2003018745A2 Method of screening for drug hypersensitivity reaction
03/06/2003WO2003018741A1 Coagulation assay reagents containing lanthanides and a protein c assay using such a lanthanide-containing reagent
03/06/2003WO2003018626A2 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton
03/06/2003WO2003018625A2 Allelic variants of herv-k18 provirus and their use in analysis
03/06/2003WO2003018612A2 Extracellular messengers
03/06/2003WO2003018595A2 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
03/06/2003WO2003018066A2 A murine genomic polynucleotide sequence encoding a g-protein coupled receptor and methods of use therefor
03/06/2003WO2003018054A1 Helicobacter pylori vaccination
03/06/2003WO2003018050A1 Gamma three protease
03/06/2003WO2003017992A2 Means for treatment of atherosclerosis
03/06/2003WO2003017755A2 Mycoplasma bovis challenge model, methods for administering m.bovis and methods for inducing pneumonic lung lesions
03/06/2003WO2003002752A3 Methods of using nick translate libraries for snp analysis
03/06/2003WO2003000729A3 Secreted polypeptide and their use in the treatment of bone disorders
03/06/2003WO2002099097A8 Novel compounds for chemiluminescense procedures
03/06/2003WO2002095036A8 A novel intein and uses thereof
03/06/2003WO2002086155A3 Method for the preferential nucleic acid amplification of selected nucleic acid regions
03/06/2003WO2002086097A3 Methods for identifying the target of a compound which inhibits cellular proliferation
03/06/2003WO2002086069A3 Secreted proteins